New drug aims to shield kidneys during heart surgery
Prevention
Recruiting now
This study tests an investigational drug called LSALT peptide to see if it can prevent or reduce acute kidney injury (AKI) in people having heart surgery with a heart-lung machine. About 240 adults will be randomly assigned to receive either the drug or a placebo. The main goal i…
Phase: PHASE2 • Sponsor: Arch Biopartners Inc. • Aim: Prevention
Last updated May 04, 2026 02:42 UTC